Keyphrases
5-fluorouracil (5-FU)
9%
Accelerated Radiotherapy
9%
Before Surgery
9%
Chemoradiation
45%
Chemotherapy
9%
Colorectal Cancer
100%
Combined Modality
9%
Complete Response
9%
Endoscopic Ultrasound
100%
Initial Staging
9%
Large Cohort
9%
Local Recurrence
9%
Locally Advanced Rectal Cancer
18%
N Stage
9%
Neoadjuvant Chemoradiotherapy (nCRT)
100%
Neoadjuvant Therapy
9%
Non-responders
9%
Overall Accuracy
9%
Pathologic T Stage
9%
Pathological Stage
18%
Postradiation Changes
9%
Recently Diagnosed
9%
Residual Disease
9%
Residual Tumor
9%
Restaging
100%
Surgical Resection
9%
T Category
9%
Ultrasound Accuracy
9%
Ultrasound Staging
18%
Medicine and Dentistry
Chemoradiation Therapy
100%
Chemoradiotherapy
63%
Endoscopic Ultrasound
100%
Fluorouracil
9%
Minimal Residual Disease
9%
Neoadjuvant Therapy
9%
Neoplasm
9%
Radiation Therapy
9%
Rectum Cancer
100%
Recurrent Disease
9%
Pharmacology, Toxicology and Pharmaceutical Science
Chemoradiation Therapy
100%
Chemotherapy
12%
Fluorouracil
12%
Minimal Residual Disease
12%
Neoplasm
12%
Rectum Cancer
100%
Recurrent Disease
12%